Elite in Cholestasis

Dr. Philip J. Rosenthal

Pediatrics | Pediatric Gastroenterology | Gastroenterology
San Francisco, CA 
Clinical Trials:Currently Recruiting for 2 Trials
47 Years of Experience
Elite in Cholestasis
San Francisco, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Philip Rosenthal is a Pediatrics specialist and a Pediatric Gastroenterologist in San Francisco, California. Dr. Rosenthal has been practicing medicine for over 47 years and is rated as an Elite provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Alagille Syndrome, Biliary Atresia, Cholestasis, Hepatitis, and Liver Transplant.

His clinical research consists of co-authoring 515 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 37 articles and participated in 2 clinical trials in the study of Cholestasis.

Specialties
Pediatrics
Pediatric Gastroenterology
Gastroenterology
Licenses
Pediatrics in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

San Francisco, CA 94143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
Enrollment Status: Recruiting
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drugs: Methylprednisolone, Equine anti-thymocyte globulin, Prednisolone, Diphenhydramine
Study Phase: Phase 2
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Enrollment Status: Recruiting
Publish Date: September 08, 2025
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Other, Drug
Study Drug: ARO-AAT
Study Phase: Phase 2
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drug: Maralixibat
Study Phase: Phase 2
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Enrollment Status: Completed
Publish Date: February 23, 2022
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Enrollment Status: Completed
Publish Date: October 26, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

514 Total Publications

Recurrent Plasmodium falciparum parasitemia and drug resistance mutations during intermittent preventive treatment of malaria in pregnancy in Uganda.
Recurrent Plasmodium falciparum parasitemia and drug resistance mutations during intermittent preventive treatment of malaria in pregnancy in Uganda.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Similar Doctors
Distinguished in Cholestasis
Dr. Subhas Banerjee
Gastroenterology
Distinguished in Cholestasis
Dr. Subhas Banerjee
Gastroenterology

Stanford Health Care

420 Broadway St, 
Redwood City, CA 
 (23.3 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Subhas Banerjee is a Gastroenterologist in Redwood City, California. Dr. Banerjee is rated as an Elite provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Choledocholithiasis, Bile Duct Stricture, Bile Duct Obstruction, Endoscopy, and Colonoscopy.

Distinguished in Cholestasis
Dr. Monique Barakat
Gastroenterology
Distinguished in Cholestasis
Dr. Monique Barakat
Gastroenterology

Stanford Health Care

420 Broadway St, 
Redwood City, CA 
 (23.3 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Monique Barakat is a Gastroenterologist in Redwood City, California. Dr. Barakat is rated as a Distinguished provider by MediFind in the treatment of Cholestasis. Her top areas of expertise are Childhood Pancreatitis, Bile Duct Obstruction, Cholestasis, Endoscopy, and Gallbladder Removal.

Distinguished in Cholestasis
Dr. James W. Ostroff
Gastroenterology
Distinguished in Cholestasis
Dr. James W. Ostroff
Gastroenterology
350 Parnassus Ave, Suite 410, 
San Francisco, CA 
 (2.1 miles away)
415-502-2112
Languages Spoken:
English
See accepted insurances

James Ostroff is a Gastroenterologist in San Francisco, California. Dr. Ostroff is rated as a Distinguished provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Childhood Pancreatitis, Chronic Pancreatitis, Bile Duct Stricture, Endoscopy, and Liver Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile